ArticleThe Importance of Guideline-Recommended Biomarker Testing and Multidisciplinary Treatment in Resectable Stage IB-IIIA Non-Small Cell Lung CancerAuthor:Gerard A. Silvestri Publish date: October 5, 2021 Read More
